GRGottumukkala Subba Raju

Gottumukkala Subba Raju

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gottumukkala Subba Raju has a total of 176 co-authors. Here are the top co-authors by number of shared publications:

  • William A. Ross

    University of Texas MD Anderson Cancer Center

    14 shared publications
  • Manoop S. Bhutani

    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

    13 shared publications
  • Phillip Lum

    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

    12 shared publications
  • John R. Stroehlein

    Gastroenterology, Univ of Texas MD Anderson Cancer Center, Houston, TX

    11 shared publications
  • Brian R. Weston

    Departments of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA

    10 shared publications
  • Jeffrey Lee

    Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

    10 shared publications

Latest Publications

  • Cholecystitis Related to Immune Checkpoint Inhibitor Therapy

    by Malek Shatila, Krishnavathana Varatharajalu, Gottumukkala Subba Raju, Anusha S. Thomas, Yinghong Wang

  • Vanished! Auto-amputated Ileal Polyp in a Patient with Lynch Syndrome

    by Abdulmalik Saleem, Abdullah S. Shaikh, Michael Overman, Sagar A. Naik, Wai Chin Foo, Eduardo Vilar, George Triadafilopoulos, Gottumukkala S. Raju, David M. Richards

  • Open Access

    Cap-fitted endoscopic mucosal resection of ≥ 20 mm colon flat lesions followed by argon plasma coagulation results in a low adenoma recurrence rate

    by Gottumukkala S. Raju, Phillip Lum, Hamzah Abu-Sbeih, William A. Ross, Selvi Thirumurthi, Ethan Miller, Patrick Lynch, Jeffrey Lee, Manoop S. Bhutani, Mehnaz Shafi, et al.

    Background and study aims Endoscopic mucosal resection (EMR) is increasingly used for the treatment of large colonic polyps (≥ 20 mm). A drawback of EMR is local adenoma recurrence. Therefore, we studied the impact of argon plasma coagulation (APC) of the EMR edge on local adenoma recurrence. Patients and methods This was a retrospective study of patients with laterally spreading tumors (LST) ≥ 20 mm, who underwent EMR from January 2009 to August 2018 and follow-up endoscopic assessment. A cap-fitted endoscope was used to assess completeness of resection by systematically inspecting the EMR defect for any macroscopic disease. This was followed by forced APC of the resection edge followed by clip closure of the defect. Surveillance colonoscopy was performed at 6 months after resection to detect recurrence. Results Two hundred forty-six patients met the inclusion criteria. Most were female (53 %) and white (80 %), with a Median age of 64 years. Median polyp size was 35 mm (interquartile range, 30–45 mm). Most polyps were located in the right colon (77 %) and were removed by piecemeal EMR (70 %). Eleven patients (5 %) had residual tumor at the resection site. Conclusions We observed low adenoma recurrence after argon plasma coagulation of the EMR edge with a cap fitted colonoscope in patients with LST ≥ 20 mm of the colon, which requires further validation in a randomized controlled study.


  • Disruption in colonic polypectomy: rocking the trend

    by Phillip S. Ge, Gottumukkala S. Raju

    Endoscopic resection is well established as first-line management of benign colorectal polyps. Even though a “complete cut” and a “safe cut” are cornerstones of colonoscopic resection, the risk of incomplete resection of large flat polyps is as high as 31 % [1]. Unless we assure high rates of complete (R0) endoscopic resection, patients may continue to be referred to surgery for fear of recurrence and cancer development [2]. Obtaining an R0 resection is important for many reasons [3]. Beyond the esthetic elegance of presenting a grateful patient with a photo of an en bloc specimen, R0 resection reduces the risk of polyp recurrence, number of surveillance examinations, and progression to cancer. Although recurrence can be managed, endoscopic treatment of recurrent lesions can be technically challenging or end in failure as a result of submucosal fibrosis. Standard endoscopic mucosal resection (EMR) is readily able to achieve an en bloc resection for colon lesions of < 20 mm in size, whereas larger lesions (> 20 mm) often require piecemeal EMR. Hybrid endoscopic submucosal dissection (ESD) and precutting EMR (EMR-P) could be utilized for en bloc resection of colon lesions of 20 – 30 mm. Hybrid ESD involves a circumferential mucosal incision followed by a limited submucosal dissection and snare resection, whereas EMR-P involves a mucosal incision followed by snare resection. Both procedures are especially relevant in the management of polyps sized 20 – 30 mm, for which standard EMR is unlikely to result in a histologically complete (R0) resection, but for which ESD may be unnecessary from the standpoint of procedural risk and time. “Hybrid ESD and precutting EMR (EMR-P) make sense from a training standpoint, as a “gateway” toward training in ESD for endoscopists and trainees experienced in EMR.” We therefore read with interest the study by Yoshida et al., which describes the efficacy of EMR-P on benign colorectal lesions 20 – 30 mm in size, or lesions 10 – 19 mm in size for which standard EMR was difficult (lesions in challenging locations [i. e. right colon or behind folds], flat morphology, poor submucosal lifting, or poor endoscope access) [4]. Either a full or partial circumferential incision was made using the snare tip, although a full circumferential incision was made in the vast majority of the lesions. Using this technique, significant differences were seen in both en bloc and R0 resection rates. Comparing EMR-P vs. standard EMR among “difficult” lesions 10 – 19 mm in size, en bloc and R0 resection rates were 98.0 % vs. 85.7 % and 87.8 % vs. 67.3 %, respectively. Comparing EMR-P vs. standard EMR among lesions 20 – 30 mm in size, en bloc and R0 resection rates were 88.6 % vs. 48.5 % and 71.4 % vs. 42.9 %, respectively. No differences were seen in perforation or post-polypectomy hemorrhage. EMR-P using the snare tip fundamentally makes sense for polyps of 20 – 30 mm. The endoscopic snare is an instrument that is universally familiar to endoscopists and does not require any additional formal training in its use. Additionally, a full circumferential incision is not necessary for EMR-P to be successful. By guaranteeing the lateral margin, recurrence can be minimized even if the EMR ends up becoming piecemeal. There are several important points worth highlighting. First, clear delineation of the margins of the lesion, including recognition of a subtle “skirt” around the obvious lesion is critical for en bloc resection, irrespective of the endoscopic resection technique utilized. A study demonstrated that laterally spreading lesions (LSTs) with a skirt were associated with a significantly higher local recurrence rate compared with LSTs without a skirt (11.4 % vs. 2.0 %), especially with piecemeal EMR (66.7 % recurrence with a skirt vs. 14.0 % without a skirt) [5]. On multivariate analysis, the presence of a skirt (odds ratio [OR] 8.29) and piecemeal resection (OR 43.48) were significant predictors of local recurrence. The presence of a skirt may potentially account for high recurrence rates observed after surgical transanal treatment such as transanal resection and transanal endoscopic microsurgery. These findings emphasize the importance of accurate assessment of the margins of the lesion. Second, studies have demonstrated the benefit of ablating the margins of the resection defect using either argon plasma coagulation or with snare tip soft coagulation, especially when en bloc resection is not achieved [6]. In the event of a partial precut, we recommend ablating the margins, and perhaps additionally marking the uncut borders of the lesion before resecting so that a “skirt” is not inadvertently left behind. Novel endoscopic tools may also facilitate greater adoption of EMR-P. EMR-P is currently typically performed using a snare or with a standard needle-type ESD knife. However, the snare tip is large and is not easy to manipulate for a full circumferential incision. ESD knives are advantageous in their ability to stabilize and place tension on the mucosal surface during circumferential incision; however, this requires the use of an additional instrument, with associated cost and learning curve. Recently, a novel multifunctional snare (Souten; Kaneka Medics, Tokyo, Japan), was introduced into the Japanese market [7]. The multifunctional snare combines a 1.5 mm needle-knife and knob-shaped tip, attached to the top of an 18.5 mm snare loop, and therefore facilitates EMR-P or hybrid ESD. The gradual dissemination of such devices is likely to allow greater adoption of EMR-P. Finally, EMR-P makes sense from a training standpoint, as a “gateway” toward training in ESD for endoscopists and trainees experienced in EMR. Current advanced endoscopy fellowships in the United States do not routinely offer exposure or formal training in ESD, although...

  • Patients with Non-Hodgkin’s Lymphoma Are at Risk of Adenomatous Colon Polyps

    by Hamzah Abu-Sbeih, Ellie Chen, Osman Ahmed, Niharika Mallepally, Phillip Lum, Wei Qiao, Hun Ju Lee, Robert Bresalier, Lan Sun Wang, Brian Weston, et al.

    Patients with non-Hodgkin’s lymphoma (NHL) are frequently referred for colonoscopy to evaluate gastrointestinal symptoms during their treatment course. Here, we described the rate of colonic adenomas in patients with NHL.


  • Open Access

    Quality of endoscopy reporting at index colonoscopy significantly impacts outcome of subsequent EMR in patients with > 20 mm colon polyps

    by Gottumukkala Raju, Phillip Lum, William Ross, Selvi Thirumurthi, Ethan Miller, Patrick Lynch, Jeffrey Lee, Manoop S. Bhutani, Mehnaz A. Shafi, Brian Weston, et al.

    Background and study aims Endoscopic mucosal resection (EMR) is safe and cost-effective in management of patients with colon polyps. However, very little is known about the actions of the referring endoscopist following identification of these lesions at index colonoscopy, and the impact of those actions on the outcome of subsequent referral for EMR. The aim of this study was to identify practices at index colonoscopy that lead to failure of subsequent EMR. Patients and methods Two hundred and eighty-nine consecutive patients with biopsy-proven non-malignant colon polyps (> 20 mm) referred for EMR were analyzed to identify practices that could be improved from the time of identifying the lesion at index colonoscopy until completion of therapy. Results EMR was abandoned at colonoscopy at the EMR center in 71 of 289 patients (24.6 %). Reasons for abandoning EMR included diagnosis of invasive carcinoma (n = 9; 12.7 %), tethered lesions (n = 21; 29.6 %) from prior endoscopic interventions, and overly large (n = 22; 31 %) and inaccessible lesions (n = 17; 24 %) for complete and safe resection whose details were not recorded in the referring endoscopy report, or polyposis syndromes (n = 2; 2.8 %) that were not recognized. Conclusions In our practice, one in four EMR attempts were abandoned as a result of inadequate diagnosis or management by the referring endoscopist, which could be improved by education on optical diagnosis of polyps, comprehensive documentation of the procedure and avoidance of interventions that preclude resection.


  • Top Cited Papers
    Open Access

    Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis

    by Hamzah Abu-Sbeih, Faisal S. Ali, Wenyi Luo, Wei Qiao, Gottumukkala S. Raju, Yinghong Wang

    Background Immune checkpoint inhibitors (ICPI) are efficacious treatments for advanced malignancies but can result in immune mediated diarrhea and colitis (IDC). Currently, the guidelines for the treatment of IDC depend only on clinical symptoms. Endoscopic and histologic features of such adverse events are not well studied in a manner that can help to gauge treatment plans. We aimed to characterize endoscopic and histologic features of IDC and to assess their association with clinical outcomes. Methods Our study included patients who had undergone endoscopy for IDC (1/2010 to 3/2018). Patients with GI infection at time of onset were excluded. High-risk endoscopic features were ulcers deeper than 2 mm, larger than 1 cm, and extensive colonic involvement. Univariate and multivariate logistic regression were performed to assess the association of endoscopic and histological features with clinical outcomes. Results A total of 182 patients was included; most were white (92%), males (65%) with a mean age of 60 years. Median time from ICPI initiation to IDC was 7 weeks. Fifty-three percent had grade 3–4 diarrhea, and 32% grade 3–4 colitis. Forty-nine patients had mucosal ulcerations, 66 non-ulcerative inflammation and 67 normal endoscopy. Calprotectin was higher in patients with ulceration (P = 0.04). The sensitivity of lactoferrin to detect histologic and endoscopic inflammation was 90% and 70% respectively. Patients who underwent endoscopy earlier than 7 days after IDC onset had shorter duration of IDC symptoms and duration of steroid treatment than those who underwent endoscopy after 7 days of IDC onset (P = 0.026 and P = 0.053, respectively). Patients who underwent endoscopy > 30 days of symptom onset required longer duration of steroids (P = 0.02), had more recurrent symptoms (P < 0.01) and received later infliximab/vedolizumab add-on therapy than did those who underwent endoscopy ≤30 days (P = 0.03). High-risk features were associated with more frequent (P = 0.03) and longer duration (P = 0.02) hospitalization and infliximab/vedolizumab requirement (P < 0.01). Patients with active histological inflammation had more recurrence (P < 0.01) and repeat endoscopy (P < 0.01). Repeat endoscopy was required in 47 patients. A multivariate logistic regression revealed that longer ICPI treatment was associated with more frequent hospitalizations (OR 1.00; 95%CI 1.00–1.01; P < 0.01) and high-risk endoscopic features were associated with the requirement of infliximab/vedolizumab (OR 3.89; 95%CI 1.68–9.01; P < 0.01). Conclusion High risk endoscopic features and active histologic inflammation represent important markers of disease severity with clinical implications and should be used in a timely manner to devise IDC-focused treatment algorithms.


  • 534 SAFETY OF ENDOSCOPIC PROCEDURES IN CANCER PATIENTS WITH THROMBOCYTOPENIA: A TERTIARY CARE CANCER CENTER EXPERIENCE

    by Hamzah Abu-Sbeih, Emmanuel Coronel, Hsiang-Chun Chen, Xuemei Wang, Manoop S. Bhutani, Jeffrey Lee, Gladis A. Shuttlesworth, Gottumukkala S. Raju, William A. Ross, John R. Stroehlein, et al.

  • 924 SAFETY OF ENDOSCOPIC PROCEDURES IN CANCER PATIENTS WITH NEUTROPENIA: FIVE YEARS CANCER CENTER EXPERIENCE

    by Hamzah Abu-Sbeih, Emmanuel Coronel, Hsiang-Chun Chen, Xuemei Wang, Manoop S. Bhutani, Jeffrey Lee, Gottumukkala S. Raju, William A. Ross, Gladis A. Shuttlesworth, Phillip Lum, et al.